{"id":98502,"date":"2025-09-06T16:14:06","date_gmt":"2025-09-06T16:14:06","guid":{"rendered":"https:\/\/pakistaninewspaperlist.com\/news\/lung-cancer-genetics-study-launches-open-source-data-platform-to-research-community\/"},"modified":"2025-09-06T16:14:06","modified_gmt":"2025-09-06T16:14:06","slug":"lung-cancer-genetics-study-launches-open-source-data-platform-to-research-community","status":"publish","type":"post","link":"https:\/\/pakistaninewspaperlist.com\/news\/lung-cancer-genetics-study-launches-open-source-data-platform-to-research-community\/","title":{"rendered":"Lung Cancer Genetics Study Launches Open-Source Data Platform to Research Community"},"content":{"rendered":"
\n

SAN FRANCISCO, Sept. 06, 2025 (GLOBE NEWSWIRE) — 23andMe Research Institute, Troper Wojcicki Philanthropies (TWP), and Lifebit today announced the official launch of an open-source data platform for the Lung Cancer Genetics Study<\/a>. Launched in 2024, the Lung Cancer Genetics Study aims to enroll 10,000 individuals diagnosed with lung cancer by 2027. The study already includes more than 1,200 participants and is one of the most diverse cohorts ever assembled for lung cancer genetics research.<\/p>\n

This marks a new phase in the study \u2014 with researchers now able to request access to de-identified data from consenting study participants and begin conducting analyses. This unique research program is powered by Lifebit\u2019s advanced end-to-end health data platform.<\/p>\n

Approved researchers who undergo a rigorous application process can gain access to a unique lung cancer dataset at no cost through Lifebit\u2019s Trusted Research Environment (TRE). This resource includes germline genotyping, self-reported health and exposure data, information on known cancer-causing driver mutations, and more. Longitudinal data sets will also be added over time. Interested researchers can begin the data access request process by contacting TWP study program manager Caitlin Nichols at caitlin@twphilanthropies.org.<\/p>\n

\u201cMore people die of lung cancer each year than breast, colon, and prostate cancer combined, yet it is one of the least funded for research. The Lung Cancer Genetics Study utilizes 23andMe\u2019s platform to attract and engage lung cancer participants from all over the country in research to provide critical data to researchers and enable them to make meaningful discoveries. This next phase of the study, set at no cost to qualified researchers, is a way to remove data silos so that the best minds can work on unlocking the genetic insights that may lead to a cure,\u201d said Anne Wojcicki, Founder and CEO of the 23andMe Research Institute.\u00a0 \u201cMy sister, Susan Wojcicki, was diagnosed with lung cancer in 2023 and unfortunately passed away in 2025.\u00a0 She was passionate about understanding the science behind lung cancer so future generations could prevent the disease and treat it. The 23andMe Lung Cancer community is a step towards achieving that.\u201d<\/p>\n

The research platform is powered by Lifebit\u2019s newly announced Health Data Ecosystem, the world\u2019s most comprehensive and AI-enhanced end-to-end solution for health data operations \u2014 already trusted by organizations including NIH, Genomics England, and 23andMe Research Institute.<\/p>\n

\u201cThis is not just a TRE \u2014 this is a full ecosystem that\u2019s purpose-built to power meaningful discovery,\u201d said Dr. Maria Dunford, CEO of Lifebit. \u201cBy launching the full suite of Lifebit solutions in support of the Lung Cancer Genetics Study, we\u2019re ensuring that patient-driven research happens faster, more securely, and with maximum impact.\u201d<\/p>\n

Patient-Led Research, Now Federated and Scalable<\/strong>
Developed by TWP in partnership with 23andMe Research Institute and more than 20 advocacy groups, the Lung Cancer Genetics Study was created to address major gaps in the field, including by eliminating institutional data silos that prevent collaboration and slow scientific progress. With the platform now live on Lifebit, researchers gain access to powerful data resources and advanced capabilities, including:<\/p>\n